Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Squitieri

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
Neuroscience and Biobehavioral Reviews|February 5, 2013
Structural MRI in Huntington's disease and recommendations for its potential use in clinical trialsNellie Georgiou-Karistianis, Rachael Scahill, Sarah J Tabrizi, et al.
Parkinsonism & Related Disorders|November 13, 2016
Early enteric neuron dysfunction in mouse and human Huntington diseaseSerena Sciacca, Mariagrazia Favellato, Michele Madonna, et al.
Journal of Personalized Medicine|June 24, 2022
Sleep Quality and Related Clinical Manifestations in Huntington DiseaseSabrina Maffi, Eugenia Scaricamazza, Simone Migliore, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 11, 2023
The validation of the Italian version of multiple sclerosis neuropsychological screening questionnaire in Huntington's diseaseSimone Migliore, Giulia D'Aurizio, Consuelo Ceccarelli, et al.
Neuroreport|November 17, 2007
Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's diseaseAnna Traficante, Barbara Riozzi, Milena Cannella, et al.
Journal of Cellular Physiology|October 15, 2010
PET translates neurophysiology into images: A review to stimulate a network between neuroimaging and basic researchGiampiero Giovacchini, Ferdinando Squitieri, Mouna Esmaeilzadeh, et al.
Journal of Cellular and Molecular Medicine|June 23, 2015
Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse modelFerdinando Squitieri, Alba Di Pardo, Mariagrazia Favellato, et al.
Experimental Brain Research|November 1, 2020
Abnormal visual scanning and impaired mental state recognition in pre-manifest Huntington diseaseMarta Olivetti Belardinelli, Thomas Hünefeldt, Roberta Meloni, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2015
Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trialJoaquim J Ferreira, Anne Rosser, David Craufurd, et al.
Neuroscience Letters|October 14, 2005
The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant choreaVittorio Maglione, Milena Cannella, Tiziana Martino, et al.
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Neuroscience and Biobehavioral Reviews|February 5, 2013
Structural MRI in Huntington's disease and recommendations for its potential use in clinical trialsNellie Georgiou-Karistianis, Rachael Scahill, Sarah J Tabrizi, et al.
Parkinsonism & Related Disorders|November 13, 2016
Early enteric neuron dysfunction in mouse and human Huntington diseaseSerena Sciacca, Mariagrazia Favellato, Michele Madonna, et al.
Journal of Personalized Medicine|June 24, 2022
Sleep Quality and Related Clinical Manifestations in Huntington DiseaseSabrina Maffi, Eugenia Scaricamazza, Simone Migliore, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 11, 2023
The validation of the Italian version of multiple sclerosis neuropsychological screening questionnaire in Huntington's diseaseSimone Migliore, Giulia D'Aurizio, Consuelo Ceccarelli, et al.
Neuroreport|November 17, 2007
Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's diseaseAnna Traficante, Barbara Riozzi, Milena Cannella, et al.
Journal of Cellular Physiology|October 15, 2010
PET translates neurophysiology into images: A review to stimulate a network between neuroimaging and basic researchGiampiero Giovacchini, Ferdinando Squitieri, Mouna Esmaeilzadeh, et al.
Journal of Cellular and Molecular Medicine|June 23, 2015
Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse modelFerdinando Squitieri, Alba Di Pardo, Mariagrazia Favellato, et al.
Experimental Brain Research|November 1, 2020
Abnormal visual scanning and impaired mental state recognition in pre-manifest Huntington diseaseMarta Olivetti Belardinelli, Thomas Hünefeldt, Roberta Meloni, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 16, 2015
Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trialJoaquim J Ferreira, Anne Rosser, David Craufurd, et al.
Neuroscience Letters|October 14, 2005
The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant choreaVittorio Maglione, Milena Cannella, Tiziana Martino, et al.
Pageof 15